Drugs and Devices

FDA approves new treatment for advanced soft tissue sarcoma

On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares